Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-15 · accession 0000950170-23-043242 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2023-08-17 | 2023-08-15 | AMLX | Mazzariello Gina | CLO | S - Sale | $20.88 | -6,164 | 49.1K | -11% | -$128.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-15 | S | D | 6,164 | $20.88 | 49,083 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.41 to $21.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |